CPhI China Company Profile

16:11 EST 20th November 2017 | BioPortfolio

News Articles [1210 Associated News Articles listed on BioPortfolio]

CPhI Worldwide opens entries for pharma awards

CPhI Worldwide has announced the opening of the 2017 CPhI Pharma Awards. The CPhI Pharma Awards, acknowledged as the most prestigious in the industry, will honor companies and individuals driving the ...

The final cut — finalists for CPhI Pharma Awards unveiled

The finalists for the 2017 CPhI Pharma Awards have been revealed by the CPhI Worldwide organisers, UBM.

Pharma Week adds shine to CPhI China expo

China, the second largest pharmaceutical market in the world, is a pharmerging giant, with around 6,500 pharmaceutical manufacturing companies producing 1,500 types of APIs. Apart having some of the

Floor fillers, day 2 — the latest from CPhI WW’s show floor

Welcome to our preview of exciting news and developments from day 2 of this year’s CPhI exhibition in Frankfurt.

China Pharma Holdings' (CPHI) CEO Zhilin Li on Q3 2017 Results - Earnings Call Transcript

From Russia with love? CPhI branded event will be discontinued

A joint event organised by UBM and Restec — CPhI @ IPhEB Russia — will be discontinued as a CPhI branded event next year with Restec set to organise a standalone IPhEB exhibition instead.

CPhI Worldwide report highlights unpredictability in CDMO growth

The overall findings of the CPhI Annual Report, reveal that the trend towards the integration of pharmaceutical outsourcing continues, with single source providers in terms of development increasingly...

FYI: The latest trends in APIs, FDFs and CMOs at CPhI

The pharma world has converged in Frankfurt, Germany for this yearâs CPhI Worldwide. In-Pharmatechnologist is here too to report the latest trends affecting the industry.

PubMed Articles [1014 Associated PubMed Articles listed on BioPortfolio]

Influenza A H5N1 and H7N9 in China: A spatial risk analysis.

Zoonotic avian influenza poses a major risk to China, and other parts of the world. H5N1 has remained endemic in China and globally for nearly two decades, and in 2013, a novel zoonotic influenza A su...

Comparative study of physico-chemical parameters of drinking water from some longevity and non-longevity areas of China.

There is an obvious regional longevity phenomenon in China and many longevity counties are located in South China. This study was carried out to find the characteristics of elemental contents of drink...

Vehicle exhaust: An overstated cause of haze in China.

Overall, total exhaust emissions of NOX, VOC and particulate matter (PM) declined, though vehicles in use continued to increase in China. This suggested that contribution of motor vehicle exhaust to h...

Emergence of novel Seneca Valley virus strains in China, 2017.

Since early 2017, several outbreaks of Seneca Valley virus (SVV) infection have re-emerged in China. We report the identification of novel SVV KS15-01-like strains showing a notable distinction with p...

China in action: national strategies to combat against emerging infectious diseases.

Clinical Trials [642 Associated Clinical Trials listed on BioPortfolio]

SYNERGY China: Assess SYNERGY Stent in China

Prospective, multicenter, single-arm study, enroll 100 patients in no more than 10 sites across China, the primary endpoint is Technical success.

China PEACE Millions Persons Project

China PEACE Millions Persons Project is a national screening project for cardiovascular disease in China. This Project was approved by National Health and Family Planning Commission (NHFPC...

Study of China Heart Failure Registry to Investigate Characteristics of Patients in China

The purpose of this study is to assess clinical characteristics, treatment, and outcome of patients hospitalized with heart failure in China and compared those with other registries

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

In a hospital-based multi-center study in China, HPV 16 was found to be the predominant type (72.9%) in cervical cancer, followed by HPV 18(8.0%) which indicated that if the HPV prophylact...

HIV Assessment in Fuyang, Anhui Province, China

The purpose of this study was to examine the needs, concerns, stigmas, and social networks of HIV infected former plasma donors (FPDs) and their relatives in Fuyang, Anhui Province, China....

Companies [515 Associated Companies listed on BioPortfolio]

CMP Media Korea Co. Ltd.

CMP Media Korea organises XpoChem and XpoPharm, as well as the XpoChem and XpoPharm conferences, and as a Korean network of CMP organising world-renowned pharmaceutical and chemical events, CPhI W...

CPhI China

Midas Pharma GmbH

April 1988 Foundation of Midas Pharmachemie GmbH November 1992 First participation in the CPhI in Wiesbaden May 1996 Foundation of Midas Chimie Fine in France July 1996 Start of the development of...

CPhI Worldwide

CPhI India

More Information about "CPhI China" on BioPortfolio

We have published hundreds of CPhI China news stories on BioPortfolio along with dozens of CPhI China Clinical Trials and PubMed Articles about CPhI China for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CPhI China Companies in our database. You can also find out about relevant CPhI China Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record